Total Payments
$3,589
2024 Payments
$154.79
Companies
9
Transactions
26
Payment Breakdown by Category
Consulting$2,250 (62.7%)
Food & Beverage$982.02 (27.4%)
Travel$342.36 (9.5%)
Education$14.14 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,250 | 1 | 62.7% |
| Food and Beverage | $982.02 | 23 | 27.4% |
| Travel and Lodging | $342.36 | 1 | 9.5% |
| Education | $14.14 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences Inc | $2,947 | 8 | $0 (2017) |
| VERTEX PHARMACEUTICALS INCORPORATED | $169.35 | 4 | $0 (2024) |
| Mylan Specialty L.P. | $106.25 | 1 | $0 (2024) |
| Chiesi USA, Inc. | $83.05 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $69.56 | 4 | $0 (2018) |
| Abbott Laboratories | $63.66 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $56.81 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $49.66 | 3 | $0 (2018) |
| Phadia US Inc. | $43.09 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $154.79 | 3 | Mylan Specialty L.P. ($106.25) |
| 2023 | $40.09 | 2 | Actelion Pharmaceuticals US, Inc. ($24.11) |
| 2022 | $18.39 | 1 | Phadia US Inc. ($18.39) |
| 2019 | $24.70 | 1 | Phadia US Inc. ($24.70) |
| 2018 | $257.30 | 5 | Vertex Pharmaceuticals Incorporated ($123.39) |
| 2017 | $3,093 | 14 | Gilead Sciences Inc ($2,947) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $32.70 | General |
| Category: Cardiology | ||||||
| 06/20/2024 | Mylan Specialty L.P. | TOBI PODHALER (Drug) | Food and Beverage | In-kind items and services | $106.25 | General |
| Category: Aminoglycosides | ||||||
| 03/29/2024 | VERTEX PHARMACEUTICALS INCORPORATED | TRIKAFTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/17/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Cardiology | ||||||
| 03/07/2023 | Vertex Pharmaceuticals Incorporated | TRIKAFTA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/23/2022 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $18.39 | General |
| Category: Allergy/Immunology | ||||||
| 12/04/2019 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $24.70 | General |
| Category: Allergy/Immunology | ||||||
| 05/15/2018 | Vertex Pharmaceuticals Incorporated | SYMDEKO (Drug) | Food and Beverage | In-kind items and services | $123.39 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 05/02/2018 | Chiesi USA, Inc. | BETHKIS (Drug), PERTZYE | Food and Beverage | Cash or cash equivalent | $83.05 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 03/23/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Respiratory | ||||||
| 02/27/2018 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), GARDASIL9 | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: VACCINE | ||||||
| 01/26/2018 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Respiratory | ||||||
| 08/10/2017 | VERTEX PHARMACEUTICALS INCORPORATED | ORKAMBI (Drug) | Education | In-kind items and services | $14.14 | General |
| Category: CYSTIC FIBROSIS | ||||||
| 06/23/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Respiratory | ||||||
| 05/19/2017 | Gilead Sciences Inc | Cayston (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: RESP | ||||||
| 05/19/2017 | Gilead Sciences Inc | Cayston (Drug) | Food and Beverage | In-kind items and services | $47.21 | General |
| Category: RESP | ||||||
| 05/19/2017 | Gilead Sciences Inc | Cayston (Drug) | Food and Beverage | In-kind items and services | $40.83 | General |
| Category: RESP | ||||||
| 05/19/2017 | Gilead Sciences Inc | Cayston (Drug) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: RESP | ||||||
| 05/19/2017 | Gilead Sciences Inc | Cayston (Drug) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: RESP | ||||||
| 05/18/2017 | Gilead Sciences Inc | Cayston (Drug) | Travel and Lodging | In-kind items and services | $342.36 | General |
| Category: RESP | ||||||
| 05/18/2017 | Gilead Sciences Inc | Cayston (Drug) | Food and Beverage | In-kind items and services | $98.65 | General |
| Category: RESP | ||||||
| 03/28/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), ASMANEX, DULERA | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: VACCINE | ||||||
| 03/24/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Respiratory | ||||||
| 02/28/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $99.14 | General |
| 02/17/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological), ASMANEX, DULERA | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: VACCINE | ||||||
About Dr. John Carl, MD
Dr. John Carl, MD is a Pediatric Pulmonology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134149107.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Carl, MD has received a total of $3,589 in payments from pharmaceutical and medical device companies, with $154.79 received in 2024. These payments were reported across 26 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($2,250).
Ad
Practice Information
- Specialty Pediatric Pulmonology
- Location Cleveland, OH
- Active Since 07/20/2006
- Last Updated 05/31/2011
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1134149107
Products in Payments
- Cayston (Drug) $2,848
- SYMDEKO (Drug) $123.39
- TOBI PODHALER (Drug) $106.25
- BETHKIS (Drug) $83.05
- SYMBICORT (Drug) $69.56
- Omnilink Elite vascular stent system (Device) $63.66
- UPTRAVI (Drug) $56.81
- PNEUMOVAX 23 (Biological) $49.66
- ImmunoCAP (Device) $43.09
- TRIKAFTA (Drug) $31.82
- ORKAMBI (Drug) $14.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Pulmonology Doctors in Cleveland
Michael Konstan, Md, MD
Pediatric Pulmonology — Payments: $148,712
Pediatric Pulmonology $148,712
Daniel Craven, Md, MD
Pediatric Pulmonology — Payments: $446.11
Pediatric Pulmonology $446.11
Carol Rosen, Md, MD
Pediatric Pulmonology — Payments: $133.73
Pediatric Pulmonology $133.73
Robert Stern, Md, MD
Pediatric Pulmonology — Payments: $102.16
Pediatric Pulmonology $102.16
Pamela Davis, Md, MD
Pediatric Pulmonology — Payments: $29.61
Pediatric Pulmonology $29.61
Laura Milgram, Md, MD
Pediatric Pulmonology — Payments: $19.99
Pediatric Pulmonology $19.99